Her entire academic and clinical career has been dedicated to the knowledge of the underlying causes of coagulation diseases for the purpose of determining the best medical approach to treatment for patients. Testifying to this from the scientific point of view are more than 240 studies published in well-reputed specialized journals as well as the positions she holds in World Federation of Hemophilia and ISTH. As Chair of the Factor VIII, Factor IX, and Rare Coagulation Disorders ISTH-SSC subcommittee she helped to developed a great number of projects that focused on harmonizing clinical methods used in laboratories as well as evaluating the effectiveness and safety of therapeutic products.